{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:18:51Z","timestamp":1791973131003,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12094-019-02257-x","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T10:02:26Z","timestamp":1576749746000},"page":"1321-1328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5810-0483","authenticated-orcid":false,"given":"I.","family":"Papageorgiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Cosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Teichgraeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Malich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"2257_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/jmri.22608","volume":"34","author":"L-M Wu","year":"2011","unstructured":"Wu L-M, Gu H-Y, Zheng J, Xu X, Lin L-H, Deng X, et al. Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis. J Magn Reson Imaging. 2011;34:128\u201335.","journal-title":"J Magn Reson Imaging."},{"key":"2257_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.mri.2012.10.017","volume":"31","author":"CM Costelloe","year":"2013","unstructured":"Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL, Ma J. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging. 2013;31:669\u201375.","journal-title":"Magn Reson Imaging."},{"key":"2257_CR3","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","volume":"29","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, Andr\u00e9 F, et al. 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)\u2020. Ann Oncol Off J Eur Soc Med Oncol. 2018;29:1634\u201357.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"Suppl 5","key":"2257_CR4","doi-asserted-by":"publisher","first-page":"v69","DOI":"10.1093\/annonc\/mdv222","volume":"26","author":"C Parker","year":"2015","unstructured":"Parker C, Gillessen S, Heidenreich A, Horwich A. ESMO Guidelines Committee Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2015;26(Suppl 5): v69\u2013v77.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"key":"2257_CR5","doi-asserted-by":"publisher","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","volume":"29","author":"D Planchard","year":"2018","unstructured":"Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2018;29:iv192\u2013iv237.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"77","key":"2257_CR6","first-page":"109","volume":"2017","author":"M Kosmin","year":"1990","unstructured":"Kosmin M, Makris A, Joshi PV, Ah-See M-L, Woolf D, Padhani AR. The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer. Eur J Cancer Oxf Engl. 1990;2017(77):109\u201316.","journal-title":"Eur J Cancer Oxf Engl"},{"key":"2257_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/bjc.2015.8","volume":"112","author":"D Di Gioia","year":"2015","unstructured":"Di Gioia D, Stieber P, Schmidt GP, Nagel D, Heinemann V, Baur-Melnyk A. Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase. Br J Cancer. 2015;112:809\u201318.","journal-title":"Br J Cancer."},{"key":"2257_CR8","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.ejca.2014.07.002","volume":"50","author":"FE Lecouvet","year":"2014","unstructured":"Lecouvet FE, Talbot JN, Messiou C, Bourguet P, Liu Y, de Souza NM. Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer. 2014;50:2519\u201331.","journal-title":"Eur J Cancer."},{"key":"2257_CR9","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/pros.23196","volume":"76","author":"A Larbi","year":"2016","unstructured":"Larbi A, Dallaudi\u00e8re B, Pasoglou V, Padhani A, Michoux N, Vande Berg BC, et al. Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease. Prostate. 2016;76:1024\u201333.","journal-title":"Prostate"},{"key":"2257_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2017.06.007","volume":"59","author":"H Goldvaser","year":"2017","unstructured":"Goldvaser H, Ribnikar D, Fazelzad R, Seruga B, Templeton AJ, Ocana A, et al. Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer. Cancer Treat Rev. 2017;59:46\u201353.","journal-title":"Cancer Treat Rev."},{"key":"2257_CR11","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6:e012799.","journal-title":"BMJ Open."},{"key":"2257_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1179\/106698107790819945","volume":"15","author":"C Cook","year":"2007","unstructured":"Cook C, Cleland J, Huijbregts P. Creation and critique of studies of diagnostic accuracy: use of the STARD and QUADAS methodological quality assessment tools. J Man Manip Ther. 2007;15:93\u2013102.","journal-title":"J Man Manip Ther."},{"key":"2257_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1148\/radiol.2017172138","volume":"285","author":"RE Lenkinski","year":"2017","unstructured":"Lenkinski RE. Gadolinium retention and deposition revisited: how the chemical properties of gadolinium-based contrast agents and the use of animal models inform us about the behavior of these agents in the human brain. Radiology. 2017;285:721\u20134.","journal-title":"Radiology"},{"key":"2257_CR14","doi-asserted-by":"publisher","first-page":"20170115","DOI":"10.1259\/bjr.20170115","volume":"90","author":"T Kanda","year":"2017","unstructured":"Kanda T, Nakai Y, Hagiwara A, Oba H, Toyoda K, Furui S. Distribution and chemical forms of gadolinium in the brain: a review. Br J Radiol. 2017;90:20170115.","journal-title":"Br J Radiol."},{"key":"2257_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","volume":"16","author":"V Gulani","year":"2017","unstructured":"Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB. International Society for Magnetic Resonance in Medicine Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017;16:564\u201370.","journal-title":"Lancet Neurol."},{"key":"2257_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4329\/wjr.v7.i8.202","volume":"7","author":"GJ O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: An update. World J Radiol. 2015;7:202\u201311.","journal-title":"World J Radiol."},{"key":"2257_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1677\/ERC-09-0012","volume":"16","author":"LJ Suva","year":"2009","unstructured":"Suva LJ, Griffin RJ, Makhoul I. Mechanisms of bone metastases of breast cancer. Endocr Relat Cancer. 2009;16:703\u201313.","journal-title":"Endocr Relat Cancer."},{"key":"2257_CR18","first-page":"3770","volume":"20","author":"F Barchetti","year":"2016","unstructured":"Barchetti F, Stagnitti A, Megna V, Al Ansari N, Marini A, Musio D, et al. Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment. Eur Rev Med Pharmacol Sci. 2016;20:3770\u20136.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"2257_CR19","first-page":"11","volume":"4","author":"K Nakanishi","year":"2005","unstructured":"Nakanishi K, Kobayashi M, Takahashi S, Nakata S, Kyakuno M, Nakaguchi K, et al. Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams. Magn Reson Med Sci MRMS Off J Jpn Soc Magn Reson Med. 2005;4:11\u20137.","journal-title":"Magn Reson Med Sci MRMS Off J Jpn Soc Magn Reson Med."},{"key":"2257_CR20","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","volume":"21","author":"H-L Yang","year":"2011","unstructured":"Yang H-L, Liu T, Wang X-M, Xu Y, Deng S-M. Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT. MRI and bone scintigraphy. Eur Radiol. 2011;21:2604\u201317.","journal-title":"MRI and bone scintigraphy. Eur Radiol."},{"key":"2257_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00432-016-2288-z","volume":"143","author":"T Liu","year":"2017","unstructured":"Liu T, Wang S, Liu H, Meng B, Zhou F, He F, et al. Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT. J Cancer Res Clin Oncol. 2017;143:457\u201365.","journal-title":"J Cancer Res Clin Oncol."},{"key":"2257_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12032-007-9027-x","volume":"25","author":"MH Yilmaz","year":"2008","unstructured":"Yilmaz MH, Ozguroglu M, Mert D, Turna H, Demir G, Adaletli I, et al. Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study. Med Oncol Northwood Lond Engl. 2008;25:257\u201363.","journal-title":"Med Oncol Northwood Lond Engl."},{"key":"2257_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00256-010-0963-8","volume":"40","author":"T Liu","year":"2011","unstructured":"Liu T, Cheng T, Xu W, Yan W-L, Liu J, Yang H-L. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer. Skeletal Radiol. 2011;40:523\u201331.","journal-title":"Skeletal Radiol."},{"key":"2257_CR24","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00256-014-1903-9","volume":"43","author":"G Shen","year":"2014","unstructured":"Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol. 2014;43:1503\u201313.","journal-title":"Skeletal Radiol."},{"key":"2257_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/0284186X.2015.1027411","volume":"55","author":"I Jambor","year":"2016","unstructured":"Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander S, et al. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18F-NaF PET\/CT and whole body 15T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol Stockh Swed. 2016;55:59\u201367.","journal-title":"Acta Oncol Stockh Swed."},{"key":"2257_CR26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ejrad.2011.01.126","volume":"81","author":"X Qu","year":"2012","unstructured":"Qu X, Huang X, Yan W, Wu L, Dai K. A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. Eur J Radiol. 2012;81:1007\u2013155.","journal-title":"Eur J Radiol."},{"key":"2257_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.clon.2010.10.002","volume":"23","author":"T Liu","year":"2011","unstructured":"Liu T, Xu J-Y, Xu W, Bai Y-R, Yan W-L, Yang H-L. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?\u2014A meta-analysis. Clin Oncol R Coll Radiol G B. 2011;23:350\u20138.","journal-title":"Clin Oncol R Coll Radiol G B."},{"key":"2257_CR28","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1111\/bcp.13718","volume":"84","author":"KA Layne","year":"2018","unstructured":"Layne KA, Dargan PI, Archer JRH, Wood DM. Gadolinium deposition and the potential for toxicological sequelae\u2014a literature review of issues surrounding gadolinium-based contrast agents. Br J Clin Pharmacol. 2018;84:2522\u201334.","journal-title":"Br J Clin Pharmacol."},{"key":"2257_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2018.07.010","volume":"86","author":"I Elbeshlawi","year":"2018","unstructured":"Elbeshlawi I, AbdelBaki MS. Safety of gadolinium administration in children. Pediatr Neurol. 2018;86:27\u2013322.","journal-title":"Pediatr Neurol."},{"key":"2257_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/(SICI)1522-2586(200004)11:4<343::AID-JMRI1>3.0.CO;2-P","volume":"11","author":"R Walker","year":"2000","unstructured":"Walker R, Kessar P, Blanchard R, Dimasi M, Harper K, DeCarvalho V, et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging. 2000;11:343\u201350.","journal-title":"J Magn Reson Imaging."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02257-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-019-02257-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02257-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:57:34Z","timestamp":1608253054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-019-02257-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s12094-019-02257-x","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"10 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All the patient data were derived from the database of our institution. Data were analyzed retrospectively, fully anonymized, in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its amendments, the European regulation 536\/2014 and its latest addendum ICH GCP E6(R2)\/2017, as well as with the guidelines of the local Institutional Review Board for clinical studies (Ref. number 2019-1288).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No informed consent is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}